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Abstract: Japanese encephalitis (JE) is the viral disease caused by Japanese encephalitis virus (JEV) transmitted 
to human by Culex mosquitoes.  As per WHO, annually 10,000–15,000 people die due to JEV in worldwide. In 
India, National Vector Borne Disease Control Programme (NVBDCP) is playing an important role for 
controlling the JEV by surveillance in each Region by Government of India. The present study was carried out 
to check the positivity rate of JEV among Acute encephalitis syndrome (AES cases) in 2013-2014 at Dhemaji 
district of Assam and to find out the risk age group and relation of JEV with living behavior. In our study it was 
found that 74.46% patients reported as AES were below 10 years and out of which 38.09 % patients were JE 
positive.  
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1. Introduction:  
 
Japanese encephalitis is a mosquito-borne disease caused by Japanese encephalitis virus (JEV) [1]. This is the 
virus from the Flaviviridae family and the virus carrier mosquitoes are mainly Culex tritaeniorhynchus and 
Culex vishnui. Domestic pigs and wild birds are the reservoirs of this virus and transmission to humans may 
cause severe symptoms include Fever, Headache, abnormal behavior (Changing mental status), Seizure, 
unconsciousness, Neck rigidity, Paralysis etc.[2-10]. As per World Health Organization (WHO) 3 billion 
persons live in countries where the JE virus is endemic and the annual incidence of the disease is 30,000–50,000 
cases [11-13]. Annually 10,000–15,000 people die due to JEV and maximum of them are children in 
comparison with adults. In 1871, first clinical case of Japanese encephalitis was reported from Japan. In 1927, 
1934 and 1935 major outbreak of Japanese encephalitis was recorded in Japan [14]. And in 1938, it was 
demonstrated that the reservoir hosts of JEV are wading ardeids and pigs.  In India the first JEV case was 
reported in 1952 and in the year 1973from the Bankura District of West Bengal JEV outbreak was reported [15-
17]. Subsequently, the disease spread to other states of the country and caused a series of outbreaks in different 
parts of the India. In the year 1978, first case of Japanese encephalitis was reported from the Lakhimpur district 
of Assam. In 1950, first Japanese encephalitis vaccine was introduced to reduce the disease burden.  These were 
inactivated mouse brain-derived vaccine (the Nakayama and/or Beijing-1 strain), made by BIKEN and 
inactivated vaccine cultivated on primary hamster kidney cells (the Beijing-3 strain). Since 1968 the Beijing-3 
strain vaccine was used in the People's Republic of China and which was replaced by them with the live-
attenuated SA14-14-2 strain Vaccine. Assam started Children vaccination since 2006 with Sivsagar and 
Dibrugarh district and in 2007, it includes Golaghat & Jorhat district. Again adult vaccination processed from 
Sivsagar district in the year 2011 with the vaccine SA14-14-2 strain. After that it includes for Kamrup (M), 
Golaghat, Jorhat, Dibrugarh, Tinsukia, Dhemaji and Lakhimpur district for adult vaccination. As per the 
manufacturer the vaccine SA14-14-2 strain having 99 % efficacy among children and Nepal has also 
successfully carried out the vaccination drive among adults [18]. 
  
2. Methodology:  
 
The study included the patients who came with clinical symptoms of AES (Acute Encephalitis Syndrome) to the 
Dhemaji Civil Hospital and North Lakhimpur Civil Hospital, Assam. The patient’s history was asked and next 
day, the patient’s living area was investigated (Field Investigation). After investigation and sample collection, 
JE IgM Capture ELISA tests were performed. Before starting the test, the reagents were allowed to reach at 
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room temperature. Further, washing solution, conjugate solution and substrate mixture were prepared. Before 
adding reagents, plates were washed with washing solution and then 50 µl positive control and 50 µl negative 
control were added to respective wells of the ELISA plate strip and 500 µl sample diluents were added with 5 µl 
serum sample in a different tube for each samples for sample dilution and diluted 50 µl serum were added to 
respective wells of the plate Further it was incubated at 37˚C for one hour [19-22]. After completion of the 
incubation, plate was washed with the help of the ELISA washer. 50 µl Japanese Encephalitis antigens were 
added and incubated at 37˚C for one hour to bind with captured human IgM  followed by washing solution. 
After the completion of washing, 50 µl Anti JE Monoclonal Antibody was added and incubated at 37˚C for one 
hour. The completion of incubation was followed by washing and Avidin-HRP. Lastly chromogenic substrate 
was added and reaction was stopped by stopping solution. The test result was calculated at 450nm with the help 
of ELISA reader machine. The positive samples were stored at -20 ˚C for further study [23, 24].  
 
3. Results:  
 
A, total of 141 (one hundred and forty one) numbers, AES samples were tested by MAC ELISA for Japanese 
encephalitis.  Out of which 52 (fifty two) samples were positive for JE. During the month of July, highest 
numbers of AES patients were reported at Dhemaji Civil Hospital and North Lakhimpur Civil Hospital. It was 
observed that the maximum AES patients were below 10 (ten) years, 61 (sixty one) Male and 44(forty four) 
Female patients were below 10 years, 15 (fifteen) numbers Male and 7(seven) numbers Female’s age range were 
11-20 Years. Above 21 years minimum numbers patients were reported as AES. During field visit investigation 
it was found that almost all area in Dhemaji District people are living with domestic pigs. No mosquito nets 
were found for pigs, No special area/distance area for Pigs (not in all cases) because of which transmission of 
JEV was easily transmittable by Culex mosquitoes. Again as it is a border district of Assam or neighboring 
district of Arunachal Pradesh (hilly Area), waters comes from Arunachal Pradesh to Dhemaji district where 
water logged and helps mosquitoes to bread. Out of 141 (one hundred and forty one) numbers AES patients 26 
(twenty six) numbers patients were died due to AES and out of this 26 (twenty six) numbers 18 (eighteen) 
numbers patients were below 10 Years i.e. the death rate of below 10 Years AES patients is 69.23% and 
positivity rate is 38.09%. Which indicate how important it is to control in Dhemaji district of Assam. The results 
are shown in Table 1 and Figures 1-4. The photos showing the life style of people in the district are shown in 
Images 1-2.  
 
Table 1: Month wise Positivity rate of Dhemaji District. 
Months Cases reported in 
year 2013 
Positive cases 
reported in year 
2013 
Cases reported in 
year 2014 
Positive cases 
reported in year 
2014 
January 0 0 0 0 
February 0 0 0 0 
March 0 0 0 0 
April 0 0 1 0 
May 0 0 6 1 
June 0 0 3 1 
July 9 0 116 48 
August 0 0 0 0 
September 2 1 0 0 
October 2 0 ---- ---- 
November 2 1 ---- --- 
December 0 0 --- --- 
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Figure 1: Cases reported of JE in year 2013. 
 
 
Figure 2: Cases reported of JE in year 2014. 
 
 
Figure 3: Age and sex wise JE positivity distribution. 
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Figure 4: Area wise positivity rate of Dhemaji District  
 
 
Image 1: People’s living behavior with pigs found during field investigation. 
 
 
Image 2: An awareness camp organized by author during field visit. 
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